Lung cancer remains a leading cause of cancer death, but mortality rates have dropped by half since the 1990s. Newly developed treatments are driving this progress, offering more effective therapies for patients. The shift reflects broader advancements in oncology, including targeted drugs and immunotherapies. Experts note that earlier detection and personalized medicine also play key roles.
As research continues, the outlook for lung cancer patients improves, signaling a new world of therapy that could further reduce death rates in the coming years.
Source: New York Times Top Stories · Summarized by HeadlinesBriefing